Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MMC Securities LLC is the investment banking and capital markets subsidiary of Marsh McLennan, providing strategic advisory services to the healthcare and life sciences industries. The firm specializes in mergers and acquisitions (M&A), capital raising, and the structuring of insurance-linked securities (ILS) to manage complex corporate risks. For biotech and pharma clients, MMC Securities offers expertise in navigating financial volatility and securing funding for research and development through innovative risk-transfer mechanisms. As part of the broader Marsh McLennan network, the firm leverages deep industry insights from sister companies like Oliver Wyman and Marsh to support global health organizations. Their services are essential for large-scale healthcare providers and life science firms seeking to optimize their capital structure and mitigate operational risks. MMC Securities is a registered broker-dealer and a key player in the convergence of the insurance and capital markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MMC Securities.